ISPOR Good Practices Reports are highly cited, expert consensus guidance recommendations that set international standards for HEOR and its use in healthcare decision making. Other ISPOR Reports provide guidance on important areas such as applications, HTA and policy, terms and definitions, and reviews. All ISPOR Reports are made freely available as part of the Society’s mission.
ISPOR Report Types
Most Recent
Clinical Outcomes
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
-
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
Economic Evaluation
Epidemiology & Public Health
Health Policy & Regulatory
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
Health Technology Assessment
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
Methodological & Statistical Research
Patient Centered Research
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
Real World Data & Information Systems
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
Specialized Treatment Areas
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
-
Medical Nutrition Terminology and Regulations in the United States and Europe
Specific Diseases & Conditions
Study Approaches
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness